US76243J1051
US76243J1051
Rhythm Pharmaceuticals, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 189.757.000 | 130.126.000 | 45.8% |
| Cost of Revenue | 19.492.000 | 13.368.000 | 45.8% |
| Gross Profit | 170.265.000 | 116.758.000 | 45.8% |
| 362.281.000 | 382.261.000 | 5.2% | |
| Operating Income | -192.016.000 | -265.503.000 | 27.7% |
| Pretax Income | -196.042.000 | -260.256.000 | 24.7% |
| Net Income Common Stockholders | -201.917.000 | -264.572.000 | 23.7% |
| -- | -- | -- | |
| -- | -- | -- |